Dergiler / Yeni Tıp Dergisi / 2011 / Cilt: 28 - Sayı: 1
Does maternal high TSH level cause breech presentation at term?
- Dergi
- Yeni Tıp Dergisi
- Sayfa
- 23–26
- DOI
- —
Özet
Makat prezentasyon en sk görülen anormal prezentasyon şeklidir ve maternal ve neonatal morbidite ve mortalite ile ilişkilidir. Son zamanlarda bozuk maternal tiroid fonksiyon testinin makat prezentasyona yol açtğ iddia edilmiştir. Bu çalşmada yüksek tiroid stimule edici hormonun (TSH) termde makat gelişe yol açp açmadğ incelenmiştir. Fatih Üniversitesi Tp Fakültesi Kadn Hastalklar ve Doğum Bölümünde, >37 gebelik haftasnda doğum yapm ş olan ve TSH değerlerine baklmş olan toplam 60 hasta çalşmaya dahil edildi. Altmş hastann 30’u makat (grup A), 30’u baş (grup B) prezentasyonunda idi. TSH seviyeleri ile makat geliş arasnda ilişki olup olmadğ SPSS 16.0 program ile değerlendirildi. A grubundaki ve B grubundaki hastalarn ortalama TSH seviyeleri srasyla 1,88 mIU/l ve 1,51 mIU/l idi ve gruplar istatistiksel olarak farkl değildi (p=0,1). Sonrasnda hastalar TSH seviyelerine göre 2 gruba ayrld (2,5 mU/l veya ≥2,5 mU/l) ancak gruplar arasnda prezentasyon yönünden istatistiksel olarak fark saptanmad. Bu çalşmada TSH seviyeleri ile makat prezentasyon arasnda herhangi bir ilişki saptanmamştr.
Abstract
Breech presentation is the most common abnormal fetal presentation and generally associated with maternal and neonatal morbidity and mortality. Recently, high thyroid stimulating hormone (TSH) levels were claimed to cause breech presentation at term. The aim of this study was to evaluate the effect TSH on breech presentation. A total of 60 patients who had delivery after 37 gestational weeks at Fatih University School of Medicine Department of Obstetrics and Gynecology and whose TSH levels were available were included in the study. 30 of 60 patients had breech presentation and 30 had cephalic presentation at delivery. Statistical analysis between TSH and breech presentation was performed by using the Statistical Package of Social Science and Problems Solutions Version 16.0 (SPSS). TSH levels were 1.88 mIU/l and 1.51 mIU/l in group A and group B, respectively. The groups were not statistically different (p=0.1). Additionally, patients were divided into 2 groups according to TSH levels (<2.5 mU/l or ≥2.5 mU/l), however the groups were also not different with regard to presentation. No relation between TSH levels and breech presentation was determined in the present study.